Skip to main content
. Author manuscript; available in PMC: 2018 Feb 23.
Published in final edited form as: JAMA Neurol. 2016 Apr;73(4):417–424. doi: 10.1001/jamaneurol.2015.4607

Figure 2. Immunoblot Results.

Figure 2

Immunoblot of human myelin proteins probed with serum of a patient with IgM myelin-associated glycoprotein antibodies and neuropathy (lane 1), a commercial antibody against human natural killer 1 (HNK-1) (lane 2), and the cerebrospinal fluid of our 3 patients with paraneoplastic opsoclonus-myoclonus syndrome and lung cancer (lanes 3-5). Note that all patient and commercial antibodies reacted with bands of similar molecular weight that are not shown by the negative control sample (lane 6).